Percutaneous transluminal coronary angioplasty: Difference between revisions
imported>David E. Volk m (wikilink to new stent article) |
imported>Robert Badgett mNo edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Percutaneous transluminal coronary angioplasty''' (PTCA), also called '''percutaneous coronary intervention''' (PCI), is "dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply."<ref>{{MeSH}}</ref> | In [[medicine]], '''Percutaneous transluminal coronary angioplasty''' (PTCA), also called '''percutaneous coronary intervention''' (PCI), is a form of [[myocardial revascularization]] in which occurs "dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply."<ref>{{MeSH}}</ref> | ||
PTCA may be a treatment for [[myocardial infarction]] and an intravascular [[stent]] may or may not be left at the site of the stenosis in order to prevent restenosis.<ref name="pmid17202455">{{cite journal |author=Keeley EC, Hillis LD |title=Primary PCI for myocardial infarction with ST-segment elevation |journal=N. Engl. J. Med. |volume=356 |issue=1 |pages=47-54 |year=2007 |pmid=17202455 |doi=10.1056/NEJMct063503}}</ref> | PTCA may be a treatment for [[myocardial infarction]] and an intravascular [[stent]] may or may not be left at the site of the stenosis in order to prevent restenosis.<ref name="pmid17202455">{{cite journal |author=Keeley EC, Hillis LD |title=Primary PCI for myocardial infarction with ST-segment elevation |journal=N. Engl. J. Med. |volume=356 |issue=1 |pages=47-54 |year=2007 |pmid=17202455 |doi=10.1056/NEJMct063503}}</ref> | ||
| Line 6: | Line 6: | ||
Stenting reduces the rate of restenosis, but should not be done if the patient cannot take [[clopidogrel]], has extensive stenoses, the stenosis is in a very small coronary artery, or if bypass surgery is planned within a few days.<ref name="pmid17202455"/> | Stenting reduces the rate of restenosis, but should not be done if the patient cannot take [[clopidogrel]], has extensive stenoses, the stenosis is in a very small coronary artery, or if bypass surgery is planned within a few days.<ref name="pmid17202455"/> | ||
Drug-eluting stents further reduce restenosis compared with bare-metal stents, but drug-eluting stents may increase the rate delayed | Drug-eluting stents further reduce restenosis compared with bare-metal stents, but drug-eluting stents may increase the rate delayed restenoses. Delayed restenosis may be prevented by taking [[aspirin]] combined with [[clopidogrel]].<ref name="pmid17202455"/> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 21:50, 25 August 2008
In medicine, Percutaneous transluminal coronary angioplasty (PTCA), also called percutaneous coronary intervention (PCI), is a form of myocardial revascularization in which occurs "dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply."[1]
PTCA may be a treatment for myocardial infarction and an intravascular stent may or may not be left at the site of the stenosis in order to prevent restenosis.[2]
Stenting reduces the rate of restenosis, but should not be done if the patient cannot take clopidogrel, has extensive stenoses, the stenosis is in a very small coronary artery, or if bypass surgery is planned within a few days.[2]
Drug-eluting stents further reduce restenosis compared with bare-metal stents, but drug-eluting stents may increase the rate delayed restenoses. Delayed restenosis may be prevented by taking aspirin combined with clopidogrel.[2]
References
- ↑ Anonymous (2024), Percutaneous transluminal coronary angioplasty (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ 2.0 2.1 2.2 Keeley EC, Hillis LD (2007). "Primary PCI for myocardial infarction with ST-segment elevation". N. Engl. J. Med. 356 (1): 47-54. DOI:10.1056/NEJMct063503. PMID 17202455. Research Blogging.